|
|
Keynote speaker Huda Zoghbi, MD
|
|
|
Huda Zoghbi, MD, is a Distinguished Service Professor at Baylor College of Medicine, a Howard Hughes Medical Institute (HHMI) Investigator, and founding Director of the Jan and Dan Duncan Neurological Research Institute at Texas Children’s Hospital.
A dynamic speaker, Dr. Zoghbi's expertise ranges from neurodevelopment to neurodegeneration. She and her teams have made significant contributions to understanding spinocerebellar ataxia type 1 (SCA1), common neurodegenerative diseases such as Alzheimer’s disease and Parkinson’s disease, and the neurological disorder Rett syndrome.
Dr. Zoghbi has trained more than 115 scientists and physician-scientists and has served on the National Academy of Medicine (NAM) Council, the National Institutes of Health (NIH) National Advisory Neurological Disorders and Stroke (NINDS) Council, and numerous scientific advisory boards. She has been elected to the National Academy of Medicine, the National Academy of Sciences, and the American Academy of Arts and Sciences.
Dr. Zoghbi’s honors include the Breakthrough Prize in Life Sciences, the National Academy of Sciences Jessie Stevenson Kovalenko Medal, the Lundbeck Foundation’s Brain Prize, and the Kavli Foundation’s Kavli Prize.
|
|
|
| Learn more
|
|
|
About The St. Jude Pediatric Translational Neuroscience Initiative
St. Jude Children’s Research Hospital is committed to transforming the treatment landscape for children living with catastrophic pediatric neurological disorders through its Pediatric Translational Neuroscience Initiative (PTNI). Launched in 2020, PTNI serves as a formalized mechanism for translational neuroscience that extends from fundamental bench science to experimental neurotherapeutics with an emphasis on working closely with stakeholders across multiple sectors, including other researchers and
institutions, patient and community groups, industry, and policymakers.
Through collaborations and thought partnership, PTNI engages thought leaders to identify promising paths forward in the pediatric neuroscience space, convening scientists, clinicians, patient advocates, and others to address the unmet needs of children with these disorders.
|
|
|
|
|
